Sunitinib Malate Market 2018-2024 Research Report Analysis, Growth Prospects, Business Overview and Growth Rate.
Brandessence Market Research is working on a new report title“Global Sunitinib Malate Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2018-2024″. Rising occurrence of pancreatic cancer, the convenience of a less drug therapeutic selections for the treatment of advanced pancreatic neuroendocrine tumors and poor diagnosis rate in the early phases of pancreatic cancer are some key drivers for Global Sunitinib Malate Market.
Scope of Global Sunitinib Malate Market Reports –
Sunitinib Malate is the small molecule, orally bioavailable malate salt of an indolinone-based multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the Food and Drug Administration (FDA) for the treatment of Carcinoma. Sunitinib Malate is having molecular formula C22H27FN4O2 so molecular weight is 398.482 g/mol. The possible antineoplastic activity of Sunitinib has managed to it being observed as an effective agent in inhibiting cell proliferation and angiogenesis. Sunitinib capsules have been approved for use in treatment of Pancreatic Neuroendocrine Tumors, Kidney Cancer and Gastrointestinal Stromal Tumor (GIST).
Mechanism of action of Sunitinib Malate is it prevents cellular signaling by targeting multiple receptor tyrosine kinases (RTKs). Sunitinib Malate also inhibits CD117 (c-KIT), the receptor tyrosine kinase that drives the many gastrointestinal stromal cell tumors. The side effects of Sunitinib Malate are Diarrhea, Heartburn, Hypertension, fatigue, Nausea and Vomiting, skin discoloration, cough, upset stomach, hair loss, fever, abdominal pain, shortness of breath, watery eyes, numbness or tingling of the arms or legs and swelling around the eyes.
Get FREE Sample Research Report @https://www.brandessenceresearch.com/pharmaceutical/sunitinib-malate-market/
Key Players for Global Sunitinib Malate Market Reports –
Global Sunitinib Malate Market reports cover prominent players like Pfizer, Topcare pharmaceutical Co. Ltd, Nanjing First Pharmaceutical Co. Ltd., J&K Scientific, Target Molecule Corp., Medichem, Biotechnica Pharma Global, Beijing Lunarsun Pharmaceutical Co. LTD, Brawn Laboratories Ltd INDIA, Hetero Drugs Ltd INDIA, Hikma Pharmaceutical plc, Jeil Pharmaceutical Co. Ltd, Natco Pharma LTD, Reliance Life Sciences Pvt. Ltd, Shilpa Medicare Ltd INDIA, Sichuan Xieli Pharmaceutical Co LTD, Synthland Ltd and Teva Pharmaceutical Industries Ltd.
Key Benefits for Global Sunitinib Malate Market Reports –
- Global Sunitinib Malate Market report covers in depth historical and forecast analysis.
- Global Sunitinib Malate Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Global market sale (K Units), Global market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
- Global Sunitinib Malate Market report helps to identify opportunities in market place.
- Global Sunitinib Malate Market report covers extensive analysis of emerging trends and competitive landscape.
Our 175 pages report provides 87 tables, 75 charts and graphs. The report covers historical and forecast data of North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Our study focuses on the most lucrative areas in the industry and the future market prospects. Market covers financial results, trends, opportunities and revenue predictions from 2018 to 2024. Significant rise in research and development activities by leading vendors.
Global Sunitinib Malate Market Segmentation –
Global Sunitinib Malate Market: By Application Analysis
- Pancreatic Neuroendocrine Tumors
- Advanced Kidney Cancer
- Gastrointestinal stromal tumor (GIST)
Global Sunitinib Malate Market: By Regional & Country Analysis
- North America
- Asia Pacific
- Southeast Asia
- Latin America
- The Middle East and Africa
- Rest of Middle East and Africa